David F. Hale
Director · Dermata Therapeutics, Inc.
- 2026
- Jan 7, 2026
- 1
Summary
Latest filing:
David F. Hale is Director of Dermata Therapeutics, Inc. (DRMA). 1 SEC Form 4 filing on record, dated 7 January 2026.
Trading pattern
InsiderAlpha's records for David F. Hale go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David F. Hale files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Munera Maria E. Bedoya-Toro - $1K in DRMA purchases and sales in the last 12 months
- Kathleen D. Scott - $13 in DRMA purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David F. Hale?
David F. Hale is a corporate insider, tracked as Director of Dermata Therapeutics, Inc. (DRMA). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David F. Hale last file a Form 4?
The only primary Form 4 on record is dated 7 January 2026.